Koninklijke Philips (NYSE:PHG) Shares Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC boosted its stake in Koninklijke Philips (NYSE:PHG) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,213 shares of the technology company’s stock after acquiring an additional 778 shares during the period. Sanctuary Advisors LLC’s holdings in Koninklijke Philips were worth $1,660,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. FMR LLC grew its position in shares of Koninklijke Philips by 0.6% during the third quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock worth $200,859,000 after acquiring an additional 35,935 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Koninklijke Philips by 315.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 245,729 shares of the technology company’s stock worth $8,040,000 after purchasing an additional 186,520 shares during the period. International Assets Investment Management LLC purchased a new position in Koninklijke Philips during the 3rd quarter worth $1,360,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Koninklijke Philips in the third quarter valued at $4,622,000. Finally, Stifel Financial Corp increased its stake in Koninklijke Philips by 16.4% in the third quarter. Stifel Financial Corp now owns 195,222 shares of the technology company’s stock valued at $6,388,000 after purchasing an additional 27,536 shares during the period. Institutional investors and hedge funds own 13.67% of the company’s stock.

Analysts Set New Price Targets

PHG has been the topic of a number of research reports. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Thursday, February 20th. Finally, Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Koninklijke Philips Trading Up 1.8 %

Shares of Koninklijke Philips stock opened at $26.01 on Tuesday. The firm has a market cap of $24.44 billion, a price-to-earnings ratio of -30.96, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a 52-week low of $19.75 and a 52-week high of $32.91. The company’s 50-day simple moving average is $26.25 and its 200-day simple moving average is $28.11. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59.

Koninklijke Philips (NYSE:PHG) last released its earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). The business had revenue of $5.38 billion for the quarter, compared to analyst estimates of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. As a group, equities research analysts anticipate that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be given a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -108.33%.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.